Lawyers for Arkansas and Johnson & Johnson make closing arguments in trial over Risperdal drug

Trial begins in Arkansas over antipsychotic drug

Johnson & Johnson Fined $1.2 Billion for Drug Labeling Failure

Imperialist Psychiatrists, Psychopathic Corporatists—But I Repeat Myself

Jury rules against drug company in Arkansas trial

Johnson & Johnson Subsidiary Hid Risks Associated With Risperdal, Drug That Made Company Billions

J&J Ordered To Pay $181M In Attys’ Fees In Risperdal Suit

Drug Maker Told Studies Would Aid It, Papers Say

J&J Duped Arkansas Doctors Over Risperdal, Lawyer Tells Jury